Fosun's tourism culture premium is about 95%. Privatization resumed on December 11, and Fosun's tourism culture (01992) was announced. The company's shares resumed trading at 9: 00 am on December 11, 2024. Fosun's tourism culture plan was privatized by agreement and its listing status was revoked. The board of directors proposed to buy back shares at a price of HK$ 7.80 per share, which was 95% higher than the closing price before suspension.German police searched Adidas' office and conducted a tax investigation. As part of the tax investigation that lasted for several years, German police searched Adidas' German headquarters on December 10th. An Adidas spokesperson said that the search operation involved customs and tax clearance regulations for goods imported into Germany from 2019.Robot concept stocks fell at the opening, Hanwang Technology fell, Hanwang Technology and Shandong Mining Machine fell, and Sanfeng Intelligent, Tuosida, Hanwei Technology, Shuanglin, Weichuang Electric, Fengli Intelligent and Wuzhou Xinchun fell more than 5%.
Japan Life Insurance: Acquisition of American Resolution Life.Japan Life Insurance: Acquisition of American Resolution Life.The central bank conducted a 7-day reverse repurchase operation of 78.6 billion yuan today, and the winning bid rate was 1.50%, which was the same as before. As 41.3 billion yuan of 7-day reverse repurchase expired today, the net investment on that day was 37.3 billion yuan.
Sora concept stocks fell, Huayang Lianzhong fell, Easy Point World, Fushi Holdings fell more than 8%, and Wanxing Technology fell nearly 5%.The net outflow of the main market exceeded 10 billion.Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13